About Dr Thomas J Hugh

• Clinical outcomes following resection of Colorectal Liver Metastases. • Quality of Life after major liver surgery for malignant tumours. • Effect of regular surveillance investigations on Quality of Life after cancer surgery. • Markers of early tumour recurrence in patients with malignant hepato-biliary and pancreatic cancer

Professor Tom Hugh is an Upper GI surgeon at Royal North Shore Hospital (RNSH) and North Shore Private Hospital, Sydney Australia. From 2006-2014 he was Head of the Department of Gastrointestinal Surgery at RNSH. Currently, he is the Chair of Surgery at the Northern Clinical School, University of Sydney and Head of the Upper GI Surgical unit at RNSH. His clinical interests include the management of benign and malignant liver tumours, gallstone disease, and repair of inguinal and complex abdominal wall hernias.

Tom Hugh was the co-ordinator of Post-Graduate Training at the Sydney Clinical Skills and Simulation Centre at RNSH from 1999- 2010. Currently, he is the Clinical Director of training in the centre. He has been a member of the Board of CanSur, a not-for-profit cancer surgery research foundation based in the Kolling Institute, RNSH since 2008. His laboratory research interests relate to xenograft mouse models and stromal biomarkers in primary colorectal cancer and colorectal liver metastases. He has supervised numerous PhD and Masters research students through the University of Sydney. Professor Hugh's main areas of clinical research include outcomes after major hepato-biliary surgery, as well as technical refinements to improve short and long-term results after surgery for inguinal and ventral hernias. He has published more than 75 papers in peer reviewed journals and author or co-author on four book chapters.
He has extensive administrative experience as Head of Department and through his multiple committee roles at RNSH over the past 18 years. From 1999-2005 he was an executive member of several professional surgical associations including the Sydney Upper Gastrointestinal Surgical Society (SUGSS) and the Australian Hepato-Pancreato-Biliary Association (AHPBA). He is the longest serving board member of the Australia and New Zealand Hepato-Pancreato-Biliary Association (ANZHPBA) executive (2006-2018). In 2016, Tom Hugh established the Surgical Education, Research and Training (SERT) Institute and the Data Analysis and Surgical Outcomes (DASO) Unit at RNSH. He continues to serve as the Director of the SERT Institute.
The Hepato-Biliary and Pancreatic Surgical Unit at Royal North Shore Hospital performs a large volume of complex hepato-biliary and pancreatic surgery mainly for malignant disease. Members of the unit have a major interest in clinical and laboratory-based research. The department hosts a large clinical database as well as supports a linked tumour bank containing more than 300 samples of frozen resected cancer specimens. This serves as a platform for clinical and laboratory research regarding outcomes in patients with hepato-biliary and pancreatic cancer malignancy. There are also subspecialty clinical databases including a prospective clinical database supervised by Tom Hugh and which contains over 1000 consecutive liver resections with long term follow up. In 2018 alone, members of the HPB unit authored a total of 26 manuscripts in peer-reviewed journals.
The unit boasts a full-time Data Manager to assist with statistical analysis and database design and maintenance, in addition to numerous administrative officers. 
The HPB unit has a close affiliation with the Kolling Institute and, in conjunction with several research scientists undertakes research into the molecular biology of HPB tumours.

<html />

Selected publications

For a comprehensive list of Dr Hugh's publicatons, please visit his Sydney Medical School profile page.